Antibody Therapeutics for Life

Notices

Press Release

PR Video

Notices


No Title Written by Written date Inquire
48   Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa   Admin   2019-01-14   1,483  
47   PharmAbcine, a clinical stage immuno-oncology company announced that PharmAbcine is so proud to be a sponsor of the 11th COGNO Annual Scientific Meeting,   Admin   2019-01-14   7,453  
46   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 73rd Annual Conference of KAOBS.   Admin   2019-01-14   1,569  
45   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine has presented as invited speaker at GBC 2018 on June 26-29, 2018   Admin   2019-01-14   1,402  
44   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.   Admin   2019-01-14   1,530  
43   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a presentation as a speaker and panelist at AFOB SUMMER FORUM 2018   Admin   2019-01-14   1,404  
42   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is attending ASCO 2018.   Admin   2019-01-14   3,413  
41   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are attending BIO 2018.   Admin   2019-01-14   1,458  
40   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the company presentation session at BIO 2018.   Admin   2019-01-14   1,354  
39   PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme.   Admin   2019-01-14   3,059